Form 8-K - Current report:
SEC Accession No. 0001493152-24-038583
Filing Date
2024-09-27
Accepted
2024-09-27 17:05:28
Documents
18
Period of Report
2024-09-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56642
2 ex1-1.htm EX-1.1 269098
3 ex5-1.htm EX-5.1 17632
4 ex5-1_001.jpg GRAPHIC 29488
5 ex5-1_002.jpg GRAPHIC 21268
  Complete submission text file 0001493152-24-038583.txt   700225

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bblg-20240927.xsd EX-101.SCH 3805
7 XBRL DEFINITION FILE bblg-20240927_def.xml EX-101.DEF 30068
8 XBRL LABEL FILE bblg-20240927_lab.xml EX-101.LAB 36757
9 XBRL PRESENTATION FILE bblg-20240927_pre.xml EX-101.PRE 27091
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5784
Mailing Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803
Business Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803 (781) 552-4452
Bone Biologics Corp (Filer) CIK: 0001419554 (see all company filings)

EIN.: 421743430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40899 | Film No.: 241335867
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
(CF Office: 08 Industrial Applications and Services)